Skip to content
★ Sign in to follow
NL

Novit, L.P.

Related company / holding
Cyclo Therapeutics, Inc.
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€186k
▼ Sales (0 ops.)
—

Latest filing published 02 Sept 2020 for Cyclo Therapeutics, Inc..

Filing timeline

BuySale
Novit, L.P.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Novit, L.P.: trading record in brief

This profile gathers the share dealings of Novit, L.P. in Cyclo Therapeutics, Inc. The record holds 4 filings, for trades running from 21 December 2018 to 27 August 2020.

On the market, this insider has only ever bought: 4 purchases, €186k in total. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2020: 2 purchases and no sales on the market.

The latest filing, published on 2 September 2020, reports an open-market purchase in Cyclo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Novit, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Related company / holdingExecutivesCyclo Therapeutics, Inc.
    0SEC
    10,000,000 sharesCommon StockSEC:0001437749-20-019217:0
    Canonical exit: 25 Nov 2020 (T+90)
  • ▲
    Related company / holdingExecutivesCyclo Therapeutics, Inc.
    200,000 USD31SEC
    2,000,000 shares@ US$0.10100.0% of flowCommon StockSEC:0001437749-20-008574:0
    Canonical exit: 23 Jul 2020 (T+90)
  • ▲
    Related company / holdingExecutivesCyclo Therapeutics, Inc.
    0SEC
    800,000 sharesCommon StockSEC:0001437749-19-011250:0
    Canonical exit: 29 Aug 2019 (T+90)
  • ▲
    Related company / holdingExecutivesCyclo Therapeutics, Inc.
    0SEC
    346,154 sharesCommon StockSEC:0001437749-18-022771:0
    Canonical exit: 21 Mar 2019 (T+90)

4 of 4 declarations